Litcius/Paper detail

FDA investigating safety risks in CAR T-cell recipients

Roxanne Nelson

2023The Lancet24 citationsDOI

Topics & Concepts

RegulatorImmunotherapyMedicineT cellOncologyInternal medicineImmunologyBiologyImmune systemCancerGeneticsGeneCAR-T cell therapy researchBiomedical Ethics and Regulation
FDA investigating safety risks in CAR T-cell recipients | Litcius